Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in perfused rat liver: Involvement of hepatic aldehyde oxidase as a detoxification enzyme

Drug Metabolism and Disposition

Volumn 28, Issue 5, 2000, Pages 538-543

  Yoshihara, Shin'ichi ^a   Harada, Keisuke ^a   Ohta, Shigeru ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALDEHYDE OXIDASE; DRUG METABOLITE; LACTAM DERIVATIVE; PYRIDINE DERIVATIVE; PYRIDONE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REGULATION; LIVER METABOLISM; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ALDEHYDE OXIDASE; ALDEHYDE OXIDOREDUCTASES; ANIMALS; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE AGENTS; HEPATITIS, TOXIC; L-LACTATE DEHYDROGENASE; LIVER; MALE; METABOLIC DETOXICATION, DRUG; RATS; RATS, WISTAR;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0034104232     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Arora PK, Riachi NJ, Harik SI and Sayre LM (1988) Chemical oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its in vivo metabolism in rat brain and liver. Biochem Biophys Res Commun 152:1339-1347.
2. Baker JK, Borne RF, Davis WM and Waters IW (1984) Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse liver preparations. Biochem Biophys Res Commun 125:484-490.
3. Beedham C (1985) Molybdenum hydroxylases as drug-metabolizing enzymes. Drug Metab Rev 16:119-156.
4. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM and Kopin IJ (1983) A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80:4546-4550.
5. Cashman JR and Ziegler DM (1986) Contribution of N-oxygenation to the metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations. Mol Pharmacol 29:163-167.
6. Castagnoli N Jr, Chiba K and Trevor AJ (1985) Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci 36:225-230.
7. Chiba K, Kubota E, Miyakawa T, Kato Y and Ishizaki T (1988) Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. J Pharmacol Exp Ther 246:1108-1115.
8. Chiba K, Trevor A and Castagnoli N Jr (1984) Metabolism of neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem Biophys Res Commun 120:574-578.
9. Coleman T, Ellis SW, Martin IJ, Lennard MS and Tucker GT (1996) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4 -implications for susceptibility to Parkinson's disease. J Pharmacol Exp Ther 277:685-690.
10. Di Monte D, Ekström G, Shinka T, Smith MT, Trevor AJ and Castagnoli N Jr (1987) Role of 1-methyl-4-phenylpyridinium ion formation and accumulation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity to isolated hepatocytes. Chem Biol Interact 62:105-116.
11. Di Monte D, Shinka T, Sanday MS, Castagnoli N Jr and Smith MT (1988) Quantitative analysis of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism in isolated rat hepatocytes. Drug Metab Dispos 16:250-255.
12. Di Monte DA, Wu EY, Irwin I, Delanney LE and Langston JW (1991) Biotransformation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes. J Pharmacol Exp Ther 258:594-600.
13. Langston JW, Ballard P, Tetrud JW and Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science (Wash DC) 219:979-980.
14. Langston JW, Forno LS, Rebert CS and Irwin I (1984) Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res 292:390-394.
15. Markey SP, Johannessen JN, Chiueh CC, Burns RS and Herkenham MA (1984) Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature (Lond) 311:464-467.
16. + and mitochondrial function. Life Sci 40:721-729.
17. +. Neurosci Lett 75:323-328.
18. Singer TP and Ramsay RR (1990) Mechanism of the neurotoxicity of MPTP. An update. FEBS Lett 274:1-8.
19. Smith MT, Ekström G, Sandy MS and Di Monte D (1987) Studies on the mechanism of 1-methyl-4-phenyl-1,2,3,6-tctrahydropyridine cytotoxicity in isolated hepatocytes. Life Sci 40:741-748.
20. Sugihara K, Kitamura S and Tatsumi K (1995) Strain differences of liver aldehyde oxidase activity in rats. Biochem Mol Biol Int 37:861-869.
21. Trevor AJ, Castagnoli N Jr, Caldera P, Ramsay RR and Singer TP (1987) Bioactivation of MPTP: Reactive metabolites and possible biochemical sequelae. Life Sci 40:713-719.
22. Usansky JI and Damani LA (1983) Oxidation of metyrapone to an α-pyridone metabolite by a mammalian molybdenum hydroxylase. J Pharm Pharmacol 35 (Suppl):72p.
23. Weissman J, Trevor A, Chiba K, Peterson LA, Caldera P, Castagnoli N Jr and Baillie T (1985) Metabolism of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by liver homogenate fractions. J Med Chem 28:997-1001.
24. Wroblewski F and La Due JS (1955) Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med 90:210-213.
25. +. Chem Res Toxicol 1:186-194.
26. +) to 1-methyl-4-phenyl-5,6-dihydro-2-pyridone. Arch Biochem Biophys 360:93-98.
27. Yoshihara S and Tatsumi K (1985) Guinea pig liver aldehyde oxidase as a sulfoxide reductase: Its purification and characterization. Arch Biochem Biophys 242:213-224.
28. Yoshihara S and Tatsumi K (1995) Metabolism of 4-aminobiphenyl and 4-acetylaminobiphenyl in perfused guinea pig liver. Biol Pharm Bull 18:872-875.
29. Yoshihara S and Tatsumi K (1997) Purification and characterization of hepatic aldehyde oxidase in male and female mice. Arch Biochem Biophys 338:29-34.